These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 18419778

  • 1. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L, Matuskova J, Adamcova M, Pelouch V, Simko J, Krajcirovicova K, Potacova A, Hulin I, Janega P, Pechanova O, Simko F.
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [Abstract] [Full Text] [Related]

  • 2. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F, Luptak I, Matuskova J, Krajcirovicova K, Sumbalova Z, Kucharska J, Gvozdjakova A, Simko J, Babal P, Pechanova O, Bernatova I.
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [Abstract] [Full Text] [Related]

  • 3. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I, Pechánová O, Pelouch V, Simko F.
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [Abstract] [Full Text] [Related]

  • 4. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F, Luptak I, Matuskova J, Babal P, Pechanova O, Bernatova I, Hulin I.
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [Abstract] [Full Text] [Related]

  • 5. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, Kojsova S, Pechanova O, Simko F.
    Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
    [Abstract] [Full Text] [Related]

  • 6. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F, Matúsková J, Lupták I, Pincíková T, Krajcírovicová K, Stvrtina S, Pomsár J, Pelouch V, Paulis L, Pechánová O.
    Physiol Res; 2007 Apr; 56 Suppl 2():S25-S32. PubMed ID: 17824810
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
    Simko F, Potácová A, Pelouch V, Paulis L, Matúsková J, Krajcírovicová K, Pechánová O, Adamcová M.
    Physiol Res; 2007 Apr; 56 Suppl 2():S55-S62. PubMed ID: 17824806
    [Abstract] [Full Text] [Related]

  • 8. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
    Kopincova J, Puzserova A, Bernatova I.
    Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
    [Abstract] [Full Text] [Related]

  • 9. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
    Pechánová O, Bernátová I, Pelouch V, Simko F.
    J Mol Cell Cardiol; 1997 Dec; 29(12):3365-74. PubMed ID: 9441842
    [Abstract] [Full Text] [Related]

  • 10. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
    Bernátová I, Pechánová O, Simko F.
    Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
    [Abstract] [Full Text] [Related]

  • 11. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
    Paulis L, Pechanova O, Zicha J, Krajcirovicova K, Barta A, Pelouch V, Adamcova M, Simko F.
    J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
    [Abstract] [Full Text] [Related]

  • 12. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Bunbupha S, Prachaney P, Kukongviriyapan U, Kukongviriyapan V, Welbat JU, Pakdeechote P.
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
    [Abstract] [Full Text] [Related]

  • 13. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
    Rauchová H, Pechánová O, Kunes J, Vokurková M, Dobesová Z, Zicha J.
    Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
    [Abstract] [Full Text] [Related]

  • 14. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T, Berthelot A, Bouhaddi M, Laurant P, André C, Guillaume Y, Demougeot C.
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [Abstract] [Full Text] [Related]

  • 15. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB, Teixeira CE, Claudino MA, De Nucci G, Zanesco A, Antunes E.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):189-96. PubMed ID: 17610863
    [Abstract] [Full Text] [Related]

  • 16. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
    Bartunek J, Dempsey S, Weinberg EO, Ito N, Tajima M, Rohrbach S, Lorell BH.
    J Am Coll Cardiol; 1998 Aug 01; 32(2):528-35. PubMed ID: 9708487
    [Abstract] [Full Text] [Related]

  • 17. Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats.
    Benova M, Herichova I, Stebelova K, Paulis L, Krajcirovicova K, Simko F, Zeman M.
    Hypertens Res; 2009 Apr 01; 32(4):242-7. PubMed ID: 19262491
    [Abstract] [Full Text] [Related]

  • 18. Effect of exercise on blood pressure in rats with chronic NOS inhibition.
    Kuru O, Sentürk UK, Demir N, Yeşilkaya A, Ergüler G, Erkiliç M.
    Eur J Appl Physiol; 2002 Jun 01; 87(2):134-40. PubMed ID: 12070623
    [Abstract] [Full Text] [Related]

  • 19. Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats.
    Zicha J, Pechánová O, Dobesová Z, Kunes J.
    Clin Sci (Lond); 2003 Oct 01; 105(4):483-9. PubMed ID: 12816535
    [Abstract] [Full Text] [Related]

  • 20. [Effect of spironolactone on L-arginine/iNOS/NO pathway of aortic adventitia in spontaneously hypertensive rats].
    Deng CN, Shen LH, Tang CS.
    Zhonghua Yi Xue Za Zhi; 2010 Feb 09; 90(6):424-6. PubMed ID: 20367944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.